Technological advancements, global market dynamics, and patient-centric approaches are all factors driving the transformation of the parenteral drug market.
Jeff Clement, Executive Director, Technical Sales – Development and Manufacturing, PCI Pharma Service
This webinar will cover the key steps and considerations involved in bringing novel nanoparticle-based therapeutics from early R&D to commercial stages.